Previous 10 | Next 10 |
Summary Biomerica is one to keep a close eye on for the future. A lack of earnings momentum and bottom line fundamentals has us sitting on the sidelines. BMRA has upcoming inflection points with its InFoods and H. pylori segments. There are inherent risks in investing in s...
InFoods ® IBS commercial launch and revenues expected before the close of calendar year 2022 Mr. Carlson is an accomplished and performance-driven Commercial and Corporate Strategy and Development Executive IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWI...
Biomerica, Inc. (Nasdaq: BMRA) announced earlier today that its Aware® Breast Self Exam device will now be sold in Walmart’s retail system. Shares of Biomerica, Inc. (Nasdaq: BMRA) gained over 26% during the premarket trading...
Gainers: Biomerica ( BMRA ) +23% . Clene ( CLNN ) +22% . Gossamer Bio ( GOSS ) +11% . Revelation Biosciences ( REVB ) +10% . Nutriband ( NTRB ) +7% . Losers: ContraFect ( CFRX ) -81% . Novavax ( NVAX ) -1...
Biomerica ( NASDAQ: BMRA ) stock surged ~28% in Thursday premarket trading after the company said its Aware Breast Self Exam device will now be sold by Walmart ( WMT ). BMRA said that Walmart will initially begin selling the product online in the U.S. Biome...
Simple at-home device to increase sensitivity in breast self exams Early detection of breast cancer saves lives Breast Cancer accounts for 1 in 3 new cases of cancer in women annually IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BM...
IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA ) today announced that the Company’s CEO will participate at the 2022 BTIG Biotechnology Conference being held in person in New York City on Monday, August 8 th and Tuesday August 9 th , 2022. ...
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16 th - 20 th , 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Spring in...
Biomerica (NASDAQ:BMRA) on Thursday said it got the European Commission's CE Mark for its hp+detect diagnostic test that detects the bacteria Helicobacter pylori. BMRA stock -0.2% to $2.78 in premarket trade. The CE marking signifies that products sold in the European Economic ...
- Attaining CE Mark is a major step toward commercialization – - World Health Organization (WHO) lists H. pylori among the 16 antibiotic-resistant bacteria that pose the greatest threat to human health and designated H. pylori as a Class 1 carcinogen...
News, Short Squeeze, Breakout and More Instantly...
inFoods ® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods ® IBS test is the first of its kind to identify specific foods that can trigger an Irritable Bowel Syndrome (I...
Biomerica (NASDAQ: BMRA) , a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agree...
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inF...